10-K/A Filing

GUIDED THERAPEUTICS INC CIK: 924515 FY 2017

Filing Information

Form Type	10-K/A
Accession Number	`0001654954-18-004170`
Period End Date	20171231
Filing Date	20180420
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	gthp-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 89 Income Statement 40 Cash Flow Statement 49 Stockholders Equity 21

Balance Sheet 89 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$160.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$279.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$278.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$716.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $160 and $279 at December 31, 2017 and 2016, respectively	`AccountsReceivableNet`	$3.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $160 and $279 at December 31, 2017 and 2016, respectively	`AccountsReceivableNet`	-	USD	Point-in-time
Series C convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory, net of reserves of $716 and $278 at December 31, 2017 and 2016, respectively	`InventoryNet`	$773.00K	USD	Point-in-time
Inventory, net of reserves of $716 and $278 at December 31, 2017 and 2016, respectively	`InventoryNet`	$265.00K	USD	Point-in-time
Series C convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series C convertible preferred stock, authorized	`PreferredStockSharesAuthorized`	9.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$111.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$259.00K	USD	Point-in-time
Series C convertible preferred stock, authorized	`PreferredStockSharesAuthorized`	9.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$380.00K	USD	Point-in-time
Series C convertible preferred stock, issued	`PreferredStockSharesIssued`	0.90	shares	Point-in-time
Series C convertible preferred stock, issued	`PreferredStockSharesIssued`	1.60	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.05M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$126.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$49.00K	USD	Point-in-time
Series C convertible preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.90	shares	Point-in-time
Series C convertible preferred stock, outstanding	`PreferredStockSharesOutstanding`	1.60	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$320.00K	USD	Point-in-time
Series C convertible preferred stock, liquidation preference	`PreferredStockLiquidationPreferenceValue`	$970.00K	USD	Point-in-time
Series C convertible preferred stock, liquidation preference	`PreferredStockLiquidationPreferenceValue`	$1.64M	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$60.00K	USD	Point-in-time
Series C1 convertible preferred stock, par value	`SeriesC1PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$109.00K	USD	Point-in-time
Series C1 convertible preferred stock, par value	`SeriesC1PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$446.00K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$489.00K	USD	Point-in-time
Series C1 convertible preferred stock, authorized	`SeriesC1PreferredStockSharesAuthorized`	20.30	shares	Point-in-time
TOTAL ASSETS	`Assets`	$1.49M	USD	Point-in-time
Series C1 convertible preferred stock, authorized	`SeriesC1PreferredStockSharesAuthorized`	20.30	shares	Point-in-time
Series C1 convertible preferred stock, issued	`SeriesC1PreferredStockSharesIssued`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, issued	`SeriesC1PreferredStockSharesIssued`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, outstanding	`SeriesC1PreferredStockSharesOutstanding`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, outstanding	`SeriesC1PreferredStockSharesOutstanding`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, liquidation preference	`SeriesC1PreferredStockLiquidationPreferenceValue`	$4.31M	USD	Point-in-time
Notes payable in default, including related parties	`ShortTermBorrowings`	$1.09M	USD	Point-in-time
Notes payable in default, including related parties	`ShortTermBorrowings`	$1.01M	USD	Point-in-time
Series C1 convertible preferred stock, liquidation preference	`SeriesC1PreferredStockLiquidationPreferenceValue`	$4.31M	USD	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$447.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$197.00K	USD	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	$2.36M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	$2.32M	USD	Point-in-time
Convertible notes payable, net	`NotesPayableCurrent`	$783.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	669.00	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	49,563.00	shares	Point-in-time
Convertible notes payable, net	`NotesPayableCurrent`	$468.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.02M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	49,563.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.60M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	669.00	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$4.25M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$2.67M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$21.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$34.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.93M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.34M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$7.96M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.42M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$19.89M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$10.76M	USD	Point-in-time
COMMITMENTS & CONTINGENCIES (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS & CONTINGENCIES (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 0.9 and 1.6 shares issued and outstanding as of December 31, 2017 and 2016, respectively. (Liquidation preference of $970 and $1,643 at December 31, 2017 and 2016, respectively).	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$355.00K	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 0.9 and 1.6 shares issued and outstanding as of December 31, 2017 and 2016, respectively. (Liquidation preference of $970 and $1,643 at December 31, 2017 and 2016, respectively).	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$601.00K	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 4.3 shares issued and outstanding as of December 31, 2017 and 2016, respectively. (Liquidation preference of $4,312 at December 31, 2017 and 2016, respectively).	`ConvertiblePreferredStockSeriesC1NonredeemableOrRedeemableIssuerOptionValue`	$701.00K	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 4.3 shares issued and outstanding as of December 31, 2017 and 2016, respectively. (Liquidation preference of $4,312 at December 31, 2017 and 2016, respectively).	`ConvertiblePreferredStockSeriesC1NonredeemableOrRedeemableIssuerOptionValue`	$701.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000 shares authorized, 49,563 and 669 shares issued and outstanding as of December 31, 2017 and 2016, respectively	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000 shares authorized, 49,563 and 669 shares issued and outstanding as of December 31, 2017 and 2016, respectively	`CommonStockValue`	$791.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$117.42M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$116.38M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-138.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-127.56M	USD	Point-in-time
TOTAL STOCKHOLDERS DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-19.40M	USD	Point-in-time
TOTAL STOCKHOLDERS DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.27M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$1.49M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$489.00K	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`SalesDevicesAndDisposables`	$605.00K	USD	Annual
Sales - devices and disposables	`SalesDevicesAndDisposables`	$244.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$493.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$530.00K	USD	Annual
Gross (loss) profit	`GrossProfit`	$-286.00K	USD	Annual
Gross (loss) profit	`GrossProfit`	$112.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$733.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$334.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$393.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$245.00K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.81M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.26M	USD	Annual
Total operating expenses	`OperatingExpenses`	$3.93M	USD	Annual
Total operating expenses	`OperatingExpenses`	$2.83M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-3.12M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-3.82M	USD	Annual
Other income	`OtherIncome`	$68.00K	USD	Annual
Other income	`OtherIncome`	$18.00K	USD	Annual
Interest expense	`InterestExpense`	$1.11M	USD	Annual
Interest expense	`InterestExpense`	$1.90M	USD	Annual
Change in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$1.68M	USD	Annual
Change in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$-6.49M	USD	Annual
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-7.58M	USD	Annual
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-150.00K	USD	Annual
LOSS FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.70M	USD	Annual
LOSS FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.97M	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
NET LOSS	`NetIncomeLoss`	$-3.97M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-10.70M	USD	Annual
DEEMED DIVIDENDS	`InvestmentIncomeDividend`	-	USD	Annual
DEEMED DIVIDENDS	`InvestmentIncomeDividend`	-	USD	Annual
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$1.02M	USD	Annual
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$278.00K	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.97M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.00M	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-24.62	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-1.29	USD	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	203.00	shares	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	8,479.00	shares	Annual

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.97M	USD	Annual
Net loss	`NetIncomeLoss`	$-10.70M	USD	Annual
Bad debt expense	`ProvisionForDoubtfulAccounts`	$174.00K	USD	Annual
Bad debt expense	`ProvisionForDoubtfulAccounts`	$221.00K	USD	Annual
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.22M	USD	Annual
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$213.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$95.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$59.00K	USD	Annual
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$-1.68M	USD	Annual
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$6.49M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$31.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$9.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-508.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-345.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-519.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-152.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-260.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$247.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$775.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$420.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-183.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-13.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.30M	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.13M	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$2.17M	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$9.55M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.14M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.80M	USD	Annual
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOfCommonStock`	$1.57M	USD	Annual
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOfCommonStock`	$50.00K	USD	Annual
Proceeds from debt financing, net of discount and debt issuance costs	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Proceeds from debt financing, net of discount and debt issuance costs	`ProceedsFromIssuanceOfDebt`	$1.96M	USD	Annual
Payments on notes	`PaymentsOfLoanCosts`	$227.00K	USD	Annual
Payments on notes	`PaymentsOfLoanCosts`	$441.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.78M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.13M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-21.00K	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-13.00K	USD	Annual
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of year	`Cash`	$1.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of year	`Cash`	$14.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaidNet`	$46.00K	USD	Annual
Cash paid for Interest	`InterestPaidNet`	-	USD	Annual
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$258.00K	USD	Annual
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$468.00K	USD	Annual
Dividends on preferred stock	`DividendsOnPreferredStock`	$278.00K	USD	Annual
Dividends on preferred stock	`DividendsOnPreferredStock`	$1.02M	USD	Annual

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$-9.27M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-5.56M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-19.40M	USD	Point-in-time
Preferred dividends	`DividendsPreferredStock`	$2.00K	USD	Annual
Preferred dividends	`DividendsPreferredStock`	$191.00K	USD	Annual
Issuance of common stock and warrants	`StockAndWarrantsIssuedDuringPeriodValueNewIssues`	$54.00K	USD	Annual
Conversion of Series C preferred stock to common stock, Amount	`ConversionOfSeriesCPreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of Series C preferred stock to common stock, Amount	`ConversionOfSeriesCPreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of debt into common stock, Amount	`DebtConversionConvertedInstrumentAmount1`	$258.00K	USD	Annual
Conversion of debt into common stock, Amount	`DebtConversionConvertedInstrumentAmount1`	$468.00K	USD	Annual
Issuance of common stock due to Series B, Tranche B warrants exchanged for shares and rights to shares, Amount	`IssuanceOfCommonStockDueToSeriesBTrancheBWarrantsExchangedForSharesAndRightsToSharesAmount`	-	USD	Annual
Series C preferred stock exchanged for Series C1 preferred stock, Amount	`SeriesCPreferredStockExchangedForSeriesC1PreferredStockAmount`	-	USD	Annual
Issuance of common stock for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$50.00K	USD	Annual
Issuance of common stock for note agreement, Amount	`IssuanceOfCommonStockForNoteAgreementAmount`	$35.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$95.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$59.00K	USD	Annual
Net Loss	`NetIncomeLoss`	$-3.97M	USD	Annual
Net Loss	`NetIncomeLoss`	$-10.70M	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$-9.27M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-5.56M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-19.40M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.